SRA's number for the day: 2
This article was originally published in SRA
The Pharmacopeial Discussion Group, which is working on harmonizing pharmacopeial standards in Japan, Europe and the US, agreed to harmonize two new excipient monographs (isomalt and hydroxypropylcellulose) during its meeting in Strasbourg, France, on 26-27 June 20131.
You may also be interested in...
Takeda, Calliditas and Bayer are set to learn whether the European Medicines Agency will grant their respective products accelerated assessment status when they file for pan-EU marketing approval.
UK health technology assessment body NICE has struck deals with the makers of Enhertu for advanced breast cancer and Kesimpta for relapsing forms of multiple sclerosis.
The developers of eleven new drugs could learn this week whether the European Medicines Agency will set them on course for pan-EU marketing approval.